Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

A, Camperdown N Clinical Trials

A listing of A, Camperdown N clinical trials actively recruiting patients volunteers.

RESULTS

Found (26) clinical trials

If you are 18+ years of age, you may qualify for a research study evaluating an investigational medication for pain associated with OA.   If you have tried medications in the past for your OA pain in the hip or knee, contact PMG Research today to see if you are eligible to ...

Phase N/A

To evaluate the efficacy of kineret (anakinra) compared to kenalog (triamcinolone acetonide) with respect to patient-assessed pain intensity in the treatment of a gouty arthritis flare.

Phase N/A

To access the efficacy, safety and tolerability of Gemcabene in subjects with severe hypertriglyceridemia.

Phase N/A

We are looking for adults 18 years of age and older with hypoparathyroidism (at time of consent) to take part in a clinical research study. The purpose of the PARALLAX Study is to measure the safety and tolerability of an injectable study drug and its effects on calcium levels in ...

Phase

To assess the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.

Phase N/A

To evaluate the efficacy and safety of K-877 in subjects with fasting triglyceride levels ≥500mg/dL and <2000 mg/dL and normal renal function. Duration of study is 52 weeks on study drug.

Phase N/A

To evaluate the efficacy and safety of MC2-01 Cream Compared to MC2-01 Cream Vehicle and Active Comparator in Subjects with Mild-to-Moderate Psoriasis Vulgaris.

Phase

This is a placebo controlled trial to test the efficacy and safety of AMG 301 in the prevention of episodic and chronic migraine. The treatment period is 12 weeks and the total study duration is 35 weeks.

Phase

The purpose of this research study is to measure the effects of a study drug on body weight in young adults that have schizophrenia, schizophreniform or bipolar 1 disorder. This study will last approximately 20 weeks. There will be 11 study visits. Each visit lasts between 1 and 4 hours. ...

Phase N/A

This is a placebo controlled trial to test the efficacy and safety of CHF 5259 (glycopyrronium bromide). This is an 8 week treatment trial.

Phase